Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Hans Gustav Hørsted, Thyregod"'
Autor:
Yousif Ahmad, James P Howard, Ahran D Arnold, Mahesh V Madhavan, Christopher M Cook, Maria Alu, Michael J Mack, Michael J Reardon, Vinod H Thourani, Samir Kapadia, Hans Gustav Hørsted Thyregod, Lars Sondergaard, Troels Højsgaard Jørgensen, William D Toff, Nicolas M Van Mieghem, Raj R Makkar, John K Forrest, Martin B Leon
Publikováno v:
European Heart Journal, 44(10), 836-852. Oxford University Press
AimsAdditional randomized clinical trial (RCT) data comparing transcatheter aortic valve implantation (TAVI) with surgical aortic valve replacement (SAVR) is available, including longer term follow-up. A meta-analysis comparing TAVI to SAVR was perfo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae9ffdafc83c8eeafcba2cd3e5fe8f60
https://pure.eur.nl/en/publications/82fcd4b5-0af3-4cd4-8737-2978bb2f149d
https://pure.eur.nl/en/publications/82fcd4b5-0af3-4cd4-8737-2978bb2f149d
Publikováno v:
JACC: Cardiovascular Interventions. 15:1849-1851
Autor:
Hans Gustav Hørsted Thyregod, Guglielmo Gallone, Giorgio Marengo, Ovidio De Filippo, Susanna Breviario, Pierluigi Omedè, Margherita Annaratone, Gabriele Crimi, Francesco Melillo, Luca Franchin, Jeffrey J. Popma, Susheel Kodali, Francesco Bruno, Michele La Torre, Gaetano M. De Ferrari, Stefano Salizzoni, Mauro Rinaldi, Luca Baldetti, Laura Marruncheddu, Federico Conrotto, Lars Søndergaard, Fabrizio D'Ascenzo, Holger Thiele
Publikováno v:
International Journal of Cardiology. 337:90-98
Introduction Recently, observational data have raised concerns about safety of selfexpandable (SE) compared to balloon-expandable (BE) valves in TAVI, although potentially limited by patient selection bias. Methods. All Randomized Controlled Trials (
Autor:
Henrik Nissen, Daniel Andreas Steinbrüchel, Petur Petursson, Bo Juel Kjeldsen, Nikolaj Ihlemann, Lars Søndergaard, Peter Skov Olsen, Troels H. Jørgensen, Hans Gustav Hørsted Thyregod
Publikováno v:
European Heart Journal
Jørgensen, T H, Thyregod, H G H, Ihlemann, N, Nissen, H, Petursson, P, Kjeldsen, B J, Steinbrüchel, D A, Olsen, P S & Søndergaard, L 2021, ' Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement ', European Heart Journal, vol. 42, no. 30, pp. 2912-2919 . https://doi.org/10.1093/eurheartj/ehab375
Jørgensen, T H, Thyregod, H G H, Ihlemann, N, Nissen, H, Petursson, P, Kjeldsen, B J, Steinbrüchel, D A, Olsen, P S & Søndergaard, L 2021, ' Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement ', European Heart Journal, vol. 42, no. 30, pp. 2912-2919 . https://doi.org/10.1093/eurheartj/ehab375
Aims The aims of the study were to compare clinical outcomes and valve durability after 8 years of follow-up in patients with symptomatic severe aortic valve stenosis at low surgical risk treated with either transcatheter aortic valve implantation (T
Publikováno v:
JACC. Cardiovascular interventions. 15(18)
Autor:
Gerhard Schymik, Julinda Mehilli, Ghada W. Mikhail, Darrel P. Francis, Hans Gustav Hørsted Thyregod, Edward L. Hannan, Corrado Tamburino, Jonathan Anderson, Paola D'Errigo, Azeem Latib, Vasileios F. Panoulas, Iqbal S. Malik, Neil Ruparelia, Zaza Samadashvili, Roxana Mehran, Antonio Colombo, Nilesh Sutaria, Petros Nihoyannopoulos, Alaide Chieffo, Martin B. Leon, Patrizia Presbitero, Anna Sonia Petronio, Sayan Sen, Andrew Chukwuemeka, Marie Claude Morice
Publikováno v:
International Journal of Cardiology. 250:66-72
Transcatheter aortic valve implantation (TAVI) for severe aortic stenosis (AS) is the first area of interventional cardiology where women are treated as often as men. In this analysis of the gender specific results of randomised controlled trials (RC
Autor:
Lars Søndergaard, Peter Skov Olsen, Hans Gustav Hørsted Thyregod, Nikolaj Ihlemann, Troels H. Jørgensen
Publikováno v:
Journal of the American College of Cardiology. 73:2785-2787
We thank Dr. Pollari and colleagues and Dr. Tang and colleagues for their letters and interest in our paper [(1)][1]. The introduction of transcatheter aortic valve replacement (TAVR) has facilitated an evidence-based paradigm shift in the treatment
Autor:
Jesper Kjaergaard, Daniel A Steinbrüchel, Anh Thuc Ngo, Peter Bo Hansen, Christian Hassager, Lars Søndergaard, Peter Skov Olsen, M. Winther-Jensen, Hans Gustav Hørsted Thyregod, Nikolaj Ihlemann
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 19:39-46
Aims Patients with severe aortic stenosis (AS) can be considered for treatment with either transcatheter (TAVR) or surgical aortic valve replacement (SAVR). The purpose of this study was to compare left ventricular (LV) remodeling in patients with AS
Autor:
Hans Gustav Hørsted Thyregod, Benjamin P. Geisler, Lars Søndergaard, Jan B. Pietzsch, Troels H. Jørgensen
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 15(11)
Aims The aim of this study was to estimate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) in patients at lower surgical risk. Methods and results Discounted costs from a societ
Autor:
Lars, Søndergaard, Nikolaj, Ihlemann, Troels H, Jørgensen, Peter Skov, Olsen, Hans Gustav Hørsted, Thyregod
Publikováno v:
Journal of the American College of Cardiology. 73(21)